Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
CET, Commissioner, Connecticut, contrary, contravening, cyber, draft, effectuated, EGFRmt, ENA, exon, insertion, Intelligence, IRA, IRR, Kymab, mt, Murine, mutant, naive, nurse, oMedian, original, outpace, path, pembrolizumab, penalize, percent, pharmacodynamic, pharmacokinetic, Prime, Rescue, Russian, Sanofi, tissue, Utah
Removed:
CE, fiscal, imaging, intention, postpone, Relief, Taxpayer
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view